Moriano, ClaraBellido Pastrana, DavidSan Román Gutiérrez, CarmenRodríguez García, Eva2024-10-302024-10-302023Moriano C, Bellido-Pastrana D, San Román Gutiérrez C, Rodríguez E. Evolution of diagnosis and treatment for lupus nephritis in Spain. Nefrologia (Engl Ed). 2023 Nov-Dec;43(6):668-75. DOI: 10.1016/j.nefroe.2023.12.0062013-2514http://hdl.handle.net/10230/68396Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus that can lead to end-stage renal disease. Many clinical and prognostic data on which our therapeutic decisions are based come from international cohorts, which have important ethnic and prognostic differences. To identify clinical and prognostic data from patients with LN in Spain, we undertook a bibliographic search of NL-related papers by Spanish authors and published in national and international journals between 2005 and 2022. According to the selected references, renal biopsy is not only essential for LN diagnosis but its repetition can be useful for the follow-up. Regarding LN treatment, standard strategy consists of an induction phase and a maintenance phase. However, as new drugs have been released, a new paradigm of treatment in a single, continuing and personalized phase has been proposed.application/pdfeng© 2023 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).info:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.nefroe.2023.12.006Lupus nephritisSpainPatient profileBelimumabVoclosporinRebiopsyinfo:eu-repo/semantics/openAccess